Non-small Cell Lung Cancer Stage ⅢA (Resectable)
1 clinical trials · Condition
◉ Watch Non-small Cell Lung Cancer Stage ⅢA (Resectable)
| Record | Firm | Date |
|---|---|---|
| Model to Predict pCR and IrAEs in Early Stage Non-small Cell Lung Cancer (NCT06250829) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2023-10-12 |
Track Non-small Cell Lung Cancer Stage ⅢA (Resectable) automatically
Every clearance here is in the API, with alerts when new ones post.